Panbela Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Panbela Therapeutics

11/08/2023 04:11

* Panbela Therapeutics Inc  PBLA.OQ  reported a quarterly
adjusted
loss of $7.95​​ per share for the quarter ended in June. The
mean expectation of three analysts for the quarter was for a
loss of $4.70 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Panbela Therapeutics Inc's reported EPS for the quarter
was a
loss of $7.95​.
    * The mean earnings estimate of analysts had risen by
about 51.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Panbela Therapeutics Inc shares had fallen by 24.8% this
quarter and lost 98.0% so far this year.
    * The company reported a quarterly loss of $5.83 million.
    * Wall Street's median 12-month price target for Panbela
Therapeutics Inc is $31.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 11 at 03:11 a.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -4.70          -7.95          Missed
 Mar. 31 2023      -16.10         -19.50         Missed
 Dec. 31 2022      -1.11 hundred  -1.70 hundred  Missed
 Sep. 30 2022      -2.64 hundred  -2.52 hundred  Beat